Designing Randomized Experiments to Predict Unit-Specific Treatment Effects
Not on the map. Why?
Abstract (arXiv)
Typically, a randomized experiment is designed to test a hypothesis about the average treatment effect and sometimes hypotheses about treatment effect variation. The results of such a study may then be used to inform policy and practice for units not in the study. In this paper, we argue that given this use, randomized experiments should instead be designed to predict unit-specific treatment effects in a well-defined population. We then consider how different sampling processes and models affect the bias, variance, and mean squared prediction error of these predictions. The results indicate, for example, that problems of generalizability (differences between samples and populations) can greatly affect bias both in predictive models and in measures of error in these models. We also examine when the average treatment effect estimate outperforms unit-specific treatment effect predictive models and implications of this for planning studies.
Key facts. Cited by 4 papers in the map (data through 14 Oct 2026). First posted on arXiv 27 Oct 2023.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2024: 3; 2025: 1.
4 papers.
- 2024Minimax Regret Estimation for Generalizing Heterogeneous Treatment Effects with Multisite Datacited by 5
- 2024Towards Generalizing Inferences from Trials to Target Populationscited by 4
- 2025Causal-EPIG: A Prediction-Oriented Active Learning Framework for CATE Estimationcited by 2
- 2024Sample size planning for conditional counterfactual mean estimation with a K-armed randomized experimentcited by 0
- 2025Causal-EPIG: A Prediction-Oriented Active Learning Framework for CATE Estimation26 Sep 2025
- 2024Minimax Regret Estimation for Generalizing Heterogeneous Treatment Effects with Multisite Data15 Dec 2024
- 2024Sample size planning for conditional counterfactual mean estimation with a K-armed randomized experiment6 Mar 2024
- 2024Towards Generalizing Inferences from Trials to Target Populations26 Feb 2024